Sumitomo Pharma America, Inc. is a subsidiary of Sumitomo Pharma Co., Ltd., a global pharmaceutical company headquartered in Japan. The company operates in the U.S., Canada, and Europe, focusing on addressing patient needs across various therapeutic areas, including oncology, urology, women's health, rare diseases, psychiatry, neurology, and cell and gene therapies. With a diverse pipeline of products and advanced technology capabilities, Sumitomo Pharma America is dedicated to accelerating the discovery, research, and development of innovative therapies to improve patient outcomes. The company is committed to ethical practices and fostering a culturally diverse workforce, aiming to create value through innovative research and development for the betterment of healthcare worldwide.